Intolerance in oral versus subcutaneous administration of methotrexate in patients with juvenile idiopathic arthritis: a cross-sectional, observational study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1546-0096
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Intolerance in oral versus subcutaneous administration of methotrexate in patients with juvenile idiopathic arthritis: a cross-sectional, observational study ; volume:12 ; number:1 ; day:17 ; month:9 ; year:2014 ; pages:1-2 ; date:9.2014
Pediatric rheumatology ; 12, Heft 1 (17.9.2014), 1-2, 9.2014
- Creator
-
Van Dijkhuizen, Pieter
Pouw, Juliëtte
Scheuern, Andrea
Hügle, Boris
Hardt, Sven
Ganser, Gerd
Kümmerle-Deschner, Jasmin
Horneff, Gerd
Holzinger, Dirk
Ćalasan, Maja Bulatović
Wulffraat, Nico
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/1546-0096-12-S1-P131
- URN
-
urn:nbn:de:101:1-2019063020174158605380
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Van Dijkhuizen, Pieter
- Pouw, Juliëtte
- Scheuern, Andrea
- Hügle, Boris
- Hardt, Sven
- Ganser, Gerd
- Kümmerle-Deschner, Jasmin
- Horneff, Gerd
- Holzinger, Dirk
- Ćalasan, Maja Bulatović
- Wulffraat, Nico
- SpringerLink (Online service)
Other Objects (12)
Methotrexate Intolerance in Juvenile Idiopathic Arthritis: Definition, Risks, and Management
Pharmacological conditioning for juvenile idiopathic arthritis: a potential solution to reduce methotrexate intolerance
Efficacy of oral versus subcutaneous methotrexate in children with juvenile idiopathic arthritis
Mutations in the MTHFR gene are not associated with Methotrexate intolerance in patients with juvenile idiopathic arthritis
Predictors of response to methotrexate in juvenile idiopathic arthritis
Methotrexate intolerance in Rheumatoid Arthritis
Utilization of Subcutaneous Methotrexate in Rheumatoid Arthritis Patients After Failure or Intolerance to Oral Methotrexate: A Multicenter Cohort Study
Successful treatment of methotrexate intolerance in juvenile idiopathic arthritis using eye movement desensitization and reprocessing – treatment protocol and preliminary results
Methotrexate restores effector T cell responsiveness in juvenile idiopathic arthritis
Predictors of response to methotrexate in juvenile idiopathic arthritis patients
Methotrexate-induced nausea in the treatment of juvenile idiopathic arthritis
High frequency of methotrexate intolerance in longstanding rheumatoid arthritis: using the methotrexate intolerance severity score (MISS)
Methotrexate Intolerance in Juvenile Idiopathic Arthritis: Definition, Risks, and Management
Pharmacological conditioning for juvenile idiopathic arthritis: a potential solution to reduce methotrexate intolerance
Efficacy of oral versus subcutaneous methotrexate in children with juvenile idiopathic arthritis
Mutations in the MTHFR gene are not associated with Methotrexate intolerance in patients with juvenile idiopathic arthritis
Predictors of response to methotrexate in juvenile idiopathic arthritis
Methotrexate intolerance in Rheumatoid Arthritis
Utilization of Subcutaneous Methotrexate in Rheumatoid Arthritis Patients After Failure or Intolerance to Oral Methotrexate: A Multicenter Cohort Study
Successful treatment of methotrexate intolerance in juvenile idiopathic arthritis using eye movement desensitization and reprocessing – treatment protocol and preliminary results
Methotrexate restores effector T cell responsiveness in juvenile idiopathic arthritis
Predictors of response to methotrexate in juvenile idiopathic arthritis patients
Methotrexate-induced nausea in the treatment of juvenile idiopathic arthritis
High frequency of methotrexate intolerance in longstanding rheumatoid arthritis: using the methotrexate intolerance severity score (MISS)
Methotrexate Intolerance in Juvenile Idiopathic Arthritis: Definition, Risks, and Management
Pharmacological conditioning for juvenile idiopathic arthritis: a potential solution to reduce methotrexate intolerance
Efficacy of oral versus subcutaneous methotrexate in children with juvenile idiopathic arthritis
Mutations in the MTHFR gene are not associated with Methotrexate intolerance in patients with juvenile idiopathic arthritis
Predictors of response to methotrexate in juvenile idiopathic arthritis
Methotrexate intolerance in Rheumatoid Arthritis
Utilization of Subcutaneous Methotrexate in Rheumatoid Arthritis Patients After Failure or Intolerance to Oral Methotrexate: A Multicenter Cohort Study
Successful treatment of methotrexate intolerance in juvenile idiopathic arthritis using eye movement desensitization and reprocessing – treatment protocol and preliminary results
Methotrexate restores effector T cell responsiveness in juvenile idiopathic arthritis
Predictors of response to methotrexate in juvenile idiopathic arthritis patients
Methotrexate-induced nausea in the treatment of juvenile idiopathic arthritis